2,0
29. Mai 2024
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Dedicated parking ; perhaps their molecular training program
Kontras
Your expertise will be viewed as threat rather than an asset. Lacks leadership with authentic expertise in molecular field. This is really a point-of-care facility. The "genomics" part is being phased out by other innovative companies.